Death Related to black market weight loss Jabs in UK

Let’s get real. People actually do die from taking the legit approved manufacturers medication - which triggers acute pancreatitis. It’s rare. But there are a number of documented cases. It happens.

As someone else here previously said, many folk have underlying health conditions they may not have even known about.

That lady’s dose could have been low. Could have been the starter dose. Could have been 100% chemically identical sema. Not an overdose, not too much. Just the starter dose.

Article in BMJ from Feb quotes 82 GLP1 related deaths reported in UK.


If you can’t access because of paywall


TLDR: The data show 18 deaths linked to tirzepatide (Mounjaro), of which 10 were linked to its use relating to weight loss and eight to its indication for type 2 diabetes.

A total of 29 reported deaths were related to semaglutide (Ozempic, Rybelsus, Wegovy), four to its use for weight loss and 25 to type 2 diabetes. A further 35 deaths were reported linked to liraglutide (Saxenda, Victoza): eight to weight loss and 27 to type 2 diabetes.

An FOI request put the numbers in June at over 100

Condolences to the families who have lost someone they loved.
 
Let’s get real. People actually do die from taking the legit approved manufacturers

Article in BMJ from Feb quotes 82 GLP1 related deaths reported in UK.


If you can’t access because of paywall


TLDR: The data show 18 deaths linked to tirzepatide (Mounjaro), of which 10 were linked to its use relating to weight loss and eight to its indication for type 2 diabetes.

A total of 29 reported deaths were related to semaglutide (Ozempic, Rybelsus, Wegovy), four to its use for weight loss and 25 to type 2 diabetes. A further 35 deaths were reported linked to liraglutide (Saxenda, Victoza): eight to weight loss and 27 to type 2 diabetes.

An FOI request put the numbers in June at over 100

Condolences to the families who have lost someone they loved.

Here is a paywall-free link to the article that appear in the British Medical Journal on GLP-1 deaths in the UK: Iacobucci (2025). GLP-1 agonists - 82 deaths linked to adverse reactions, UK data show. Brit. Med. J. 388, r390, https://1drv.ms/b/c/d63cedb6db1eefc3/Ecic5FOEGxtEqsn_jc74aOIBWX6YqBmBLCobvC5yRFSXNQ?e=MggbVV.
 
Last edited:
Top Bottom